Publication | Open Access

Discovery of 4-{1-[({1-[4-(trifluoromethyl)benzyl]-1H-indol-7-yl}carbonyl)amino]cyclopropyl}benzoic acid (MF-766), a highly potent and selective EP4 antagonist for treating inflammatory pain

InflammationMedicinal ChemistryAnti-inflammatoryHealth SciencesInflammatory PainBenzoic AcidPain MedicineMedicineMolecular PainPharmacological AgentPain ManagementPharmacologyPharmaceutical ChemistryDrug DiscoverySelective Ep4 AntagonistPain Research